|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Landero J, Touloei K and Glick BP:
Invasive ductal breast carcinoma underneath a lipoma in a male
patient. J Clin Aesthet Dermatol. 5:33–37. 2012.PubMed/NCBI
|
|
3
|
Hurvitz SA, Hu Y, O'Brien N and Finn RS:
Current approaches and future directions in the treatment of
HER2-positive breast cancer. Cancer Treat Rev. 39:219–229. 2013.
View Article : Google Scholar
|
|
4
|
Jia T, Zhang L, Duan Y, Zhang M, Wang G,
Zhang J and Zhao Z: The differential susceptibilities of MCF-7 and
MDA-MB-231 cells to the cytotoxic effects of curcumin are
associated with the PI3K/Akt-SKP2-Cip/Kips pathway. Cancer Cell
Int. 14:1262014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jovanovic J, Rønneberg JA, Tost J and
Kristensen V: The epigenetics of breast cancer. Mol Oncol.
4:242–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parton M, Dowsett M and Smith I: Studies
of apoptosis in breast cancer. BMJ. 322:1528–1532. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim K, Chie EK, Han W, Noh DY, Oh DY, Im
SA, Kim TY, Bang YJ and Ha SW: Prognostic factors affecting the
outcome of salvage radiotherapy for isolated locoregional
recurrence after mastectomy. Am J Clin Oncol. 33:23–27. 2010.
View Article : Google Scholar
|
|
9
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prensner JR, Iyer MK, Sahu A, Asangani IA,
Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, et al:
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer
and antagonizes the SWI/SNF complex. Nat Genet. 45:1392–1398. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen G, Sun W, Hua X, Zeng W and Yang L:
Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma
carcinogenesis by modulating miR-363-5p/S100A1 pathway. Gene.
645:76–84. 2018. View Article : Google Scholar
|
|
18
|
Li J, Zhao Y, Lu Y, Ritchie W, Grau G,
Vadas MA and Gamble JR: The poly-cistronic miR-23-27-24 complexes
target endothelial cell junctions: Differential functional and
molecular effects of miR-23a and miR-23b. Mol Ther Nucleic Acids.
5:e3542016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li CY, Liang GY, Yao WZ, Sui J, Shen X,
Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Integrated
analysis of long non-coding RNA competing interactions reveals the
potential role in progression of human gastric cancer. Int J Oncol.
48:1965–1976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rong L, Zhao R and Lu J: Highly expressed
long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer
progression via Wnt/β-catenin signaling. Biochem Biophys Res
Commun. 484:586–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bao J, Zhou C, Zhang J, Mo J, Ye Q, He J
and Diao J: Upregulation of the long noncoding RNA FOXD2-AS1
predicts poor prognosis in esophageal squamous cell carcinoma.
Cancer Biomark. 21:527–533. 2018. View Article : Google Scholar
|
|
22
|
Shang W, Tang Z, Gao Y, Qi H, Su X, Zhang
Y and Yang R: lncRNA RNCR3 promotes Chop expression by sponging
miR-185-5p during MDSC differentiation. Oncotarget.
8:111754–111769. 2017. View Article : Google Scholar
|
|
23
|
An Q, Zhou L and Xu N: Long noncoding RNA
FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer
by sponging miR-143. Biomed Pharmacother. 103:415–420. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kalli S, Semine A, Cohen S, Naber SP,
Makim SS and Bahl M: American Joint Committee on Cancer's Staging
System for Breast Cancer, Eighth Edition: What the radiologist
needs to know. Radiographics. 38:1921–1933. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−∆∆C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
26
|
Peng F, Li TT, Wang KL, Xiao GQ, Wang JH,
Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, et al: H19/let-7/LIN28
reciprocal negative regulatory circuit promotes breast cancer stem
cell maintenance. Cell Death Dis. 8:e25692017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai Z and Liu Q: Cell Cycle regulation in
treatment of breast cancer. Adv Exp Med Biol. 1026:251–270. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang T: Association between HIF1α 1772 C/T
polymorphism and breast cancer susceptibility: A systematic review.
Crit Rev Eukaryot Gene Expr. 27:297–304. 2017. View Article : Google Scholar
|
|
29
|
Wang J and Sun G: FOXO1-MALAT1-miR-26a-5p
feedback loop mediates proliferation and migration in osteosarcoma
cells. Oncol Res. 25:1517–1527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Y, Choi DS, Sheng J, Ensor JE, Liang
DH, Rodriguez-Aguayo C, Polley A, Benz S, Elemento O, Verma A, et
al: HN1L promotes triple-negative breast cancer stem cells through
LEPR-STAT3 pathway. Stem Cell Reports. 10:212–227. 2018. View Article : Google Scholar :
|
|
31
|
Safa AR: Resistance to cell death and its
modulation in cancer stem cells. Crit Rev Oncog. 21:203–219. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao YL, Zhao ZS, Zhang MY, Han LJ, Dong YJ
and Xu B: Long noncoding RNA PVT1 facilitates cervical cancer
progression via negative regulating of miR-424. Oncol Res.
25:1391–1398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koshizuka K, Hanazawa T, Kikkawa N, Katada
K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y and Seki N:
Antitumor miR-150-5p and miR-150-3p inhibit cancer cell
aggressiveness by targeting SPOCK1 in head and neck squamous cell
carcinoma. Auris Nasus Larynx. 45:854–865. 2018. View Article : Google Scholar
|
|
34
|
Cui XB, Zhang SM, Xu YX, Dang HW, Liu CX,
Wang LH, Yang L, Hu JM, Liang WH, Jiang JF, et al: PFN2, a novel
marker of unfavorable prognosis, is a potential therapeutic target
involved in esophageal squamous cell carcinoma. J Transl Med.
14:1372016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim MJ, Lee YS, Han GY, Lee HN, Ahn C and
Kim CW: Profilin 2 promotes migration, invasion, and stemness of
HT29 human colorectal cancer stem cells. Biosci Biotechnol Biochem.
79:1438–1446. 2015. View Article : Google Scholar : PubMed/NCBI
|
